http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109232322-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C269-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-24 |
filingDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109232322-B |
titleOfInvention | Synthetic method of valiolamine key intermediate |
abstract | The invention relates to a synthesis method of a key intermediate IV. The validamycin amine is used as a raw material, and is subjected to amino protection, 4-hydroxymethyl iodo, 1,2 and 3-hydroxyl protection and then dehydroiodination to form a double bond to obtain a key intermediate IV, wherein the intermediate IV can be used for synthesizing valiolamine (valienamine). |
priorityDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.